Ah. Merrill et al., SPHINGOLIPIDS - THE ENIGMATIC LIPID CLASS - BIOCHEMISTRY, PHYSIOLOGY,AND PATHOPHYSIOLOGY, Toxicology and applied pharmacology, 142(1), 1997, pp. 208-225
The ''sphingosin'' backbone of sphingolipids was so named by J. L. W.
Thudichum in 1884 for its enigmatic (''Sphinx-like'') properties. Alth
ough still an elusive class of lipids, research on the involvement of
sphingolipids in the signal transduction pathways that mediate cell gr
owth, differentiation, multiple cell functions, and cell death has bee
n rapidly expanding our understanding of these compounds. In addition
to the newly discovered role of ceramide as an intracellular second me
ssenger for tumor necrosis factor-alpha, IL-1 beta, and other cytokine
s, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabo
lites have recently been demonstrated to modulate cellular calcium hom
eostasis and cell proliferation. Perturbation of sphingolipid metaboli
sm using synthetic and naturally occurring inhibitors of key enzymes o
f the biosynthetic pathways is aiding the characterization of these pr
ocesses; for examples, inhibition of cerebroside synthase has indicate
d a role for ceramide in cellular stress responses including heat shoc
k, and inhibition of ceramide synthase (by fumonisins) has revealed th
e role of disruption of sphingolipid metabolism in several animal dise
ases. Fumonisins are currently the focus of a FDA long-term tumor stud
y. This review summarizes recent research on (i) the role of sphingoli
pids as important components of the diet, (ii) the role of sphingoid b
ase metabolites and the ceramide cycle in expression of genes regulati
ng cell growth, differentiation, and apoptosis, (iii) the use of cereb
roside synthase inhibitors as tools for understanding the role of sphi
ngolipids as mediators of cell cycle progression, renal disease, and s
tress responses, and (iv) the involvement of disrupted sphingolipid me
tabolism in animal disease and cellular deregulation associated with e
xposure to inhibitors of ceramide synthase and serine palmitoyltransfe
rase, key enzymes in de novo sphingolipid biosynthesis. These findings
illustrate how an understanding of the function of sphingolipids can
help solve questions in toxicology and this is undoubtedly only the be
ginning of this story. (C) 1997 Academic Press